Sarah Luppino
Associate @ M Ventures
Amsterdam, The Netherlands
Sarah Luppino is a Series A investor at M Ventures in Amsterdam focused on Medical and Life Science. Sarah joined M Ventures in January 2021 as an Associate on the Technology team, focusing on investments for Frontier Tech & Sustainability and Performance Materials. Previously, she was a business strategy consultant with Mars & Co., a global boutique consulting firm. She has also worked with startups in the nanotechnology and energy &sustainability sectors. She earned her Ph.D. from MIT in organic chemistry, where her dissertation focused on the synthesis and applications of new semiconductor materials. Sarah is based in Amsterdam.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Sarah Luppino invests in
Stages Sarah Luppino invests in
Countries Sarah Luppino invests in
Investment Focus
Industry
- Medical 1 (100%)
- Life Science 1 (100%)
- Biotechnology 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Concerto Biosciences
|
Concerto Biosciences discovers and develops specific combinations of microbial ensembles. Using kChip, a patented, high-throughput platform that constructs and screens millions of defined microbial communities - Concerto creates massive data sets on how microbes function when growing in complex communities. From these data, Concerto directlydiscovers microbial ensembles that perform a desired task and learns design rules for ensemble engineering. | $24.5M / Series A / Mar 22, 2022 |
Co-Investors
Excelestar Ventures
1 deal together
Horizons Ventures
1 deal together
MassVentures
1 deal together
Safar Partners
1 deal together
About M Ventures
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
M Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Christian Patze
Associate, Performance Materials
|
|||
Noga Yerushalmi
Head of Israel Bio-incubator
|
|||
|
Sarah Luppino
Associate
|
|||
Alexander Hoffmann
Principal
|
|||
Alicia Iruzun Lafitte
Principal
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Sarah Luppino invest in?
Sarah Luppino invests primarily in Medical, Life Science and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Sarah Luppino last invest?
The most recent investment recorded for Sarah Luppino closed in Mar 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
